Polyrizon (PLRZ) announced Monday the publication of its national phase patent application with the US Patent and Trademark Office.
The application covers its core nasal technologies: capture and contain, a blocker system, and trap and target, designed for advanced drug delivery.
US patent applications are generally published after 18 months from the date of filing.
Shares of the company jumped more than 60% in recent premarket activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。